Navigation Links
Alimera Announces Positive Results From the Two Phase 3 FAME(TM) Trials of Iluvien(R) in Patients With Diabetic Macular Edema
Date:12/23/2009

s with the blurring of central vision or acute vision loss. The severity of this blurring may range from mild to profound loss of vision. The Wisconsin Epidemiologic Study of Diabetic Retinopathy found that over a 10-year period approximately 19% of diabetics studied were diagnosed with DME. Based on this study and the current U.S. diabetic population, Alimera estimates that there will be an incidence of approximately 340,000 cases of DME annually in the United States. As the population of people with diabetes increases, Alimera expects the annual incidence of diagnosed DME to increase as well.

About Iluvien®

Iluvien is an investigative, extended release intravitreal insert that Alimera is developing for the treatment of DME. Each Iluvien insert is designed to provide a therapeutic effect of up to 36 months by delivering sustained sub-microgram levels of fluocinolone acetonide (FA). Iluvien is inserted in the back of the patient's eye to a position that takes advantage of the eye's natural fluid dynamics. Iluvien is inserted with a device that employs a 25-gauge needle, which allows for a self-sealing wound.

About Alimera Sciences, Inc.

Alimera Sciences is a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. Presently the company is focused on diseases affecting the back of the eye, or retina. Its most advanced product candidate is Iluvien®, which is being developed for the treatment of diabetic macular edema, or DME.

Alimera is also pursuing the development, license and acquisition of rights to compounds and technologies with the potential to treat diseases of the eye that Alimera believes are not well treated by current therapies. Alimera has entered into agreements with Emory University, where by it acquired exclusive, worldwide rights under patent applications covering two classes of nicotin
'/>"/>

SOURCE Alimera Sciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Alimera Sciences Announces Presentation of Data From the 12-Month Interim Readout of the Human PK Iluvien(TM) Study at ARVO 2009 Annual Meeting
2. Alimera Sciences Iluvien(TM) Phase 3 Studies for DME Pass Final DSMB Review Prior to October Readout
3. Alimera Reports Favorable Safety and Efficacy Results From the 12-Month Interim Readout of the Human PK Iluvien(TM) Study
4. Alimera Reports Results From the Six-Month Interim Readout of the Human PK Iluvien(TM) Study
5. DSMB Again Supports Continuation of Alimera Sciences Phase 3 Clinical Trial of Iluvien(TM) for the Treatment of DME
6. Alimera Reports Results From the Three-Month Interim Readout of the Human PK Medidur(TM) FA Study
7. China Medicine Announces Changes to Management Team
8. PDI Announces New Pharmaceutical Services Business Win With a Top 5 Pharmaceutical Company
9. Jennerex Announces Presentations at Upcoming Conferences
10. Macomb County Announces Final 2009 H1N1 Clinic
11. Access MediQuip Announces Release of Partners in Focus Provider Portal
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... 31, 2015  The departments of Drug and Alcohol ... Gaudenzia Concept 90 to raise awareness for International Overdose ... Pennsylvania and help more Pennsylvanians ... recovery through the Building Bridges to Recovery ... every day to a disease that is fully treatable, ...
(Date:8/31/2015)... Mich. , Aug. 31, 2015  Diplomat Pharmacy, Inc. ... has announced that Phil Hagerman , Chairman & CEO, ... upcoming investor conferences. Mr. Hagerman and Mr. ... Healthcare Conference in Boston on Wednesday, ... Hagerman and Mr. Whelan are also scheduled to participate in ...
(Date:8/31/2015)... Soligenix, Inc. (OTCQB: SNGX) (Soligenix or ... that address unmet medical needs in the areas ... has completed enrollment of the additional subjects, as ... this year, into the company,s Phase 2 study ... regulator (IDR) and is being evaluated as a ...
Breaking Medicine Technology:Pennsylvania Departments of Drug & Alcohol Programs and Health Kick-off Second Annual Building Bridges to Recovery Initiative 2Diplomat to Participate in Upcoming Investor Conferences 2Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 2Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 3Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 4Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 5Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 6
... 8, 2011 Elsevier Business Intelligence , ... conferences, is hosting Windhover,s 21 st Pharmaceutical Strategic ... in New York, NY. PSA is the only ... a diverse mix of pharma,s top talent. It,s an opportunity ...
... Medical, a leading manufacturer of integrated medical imaging display and ... year, Carrot Medical achieved significant growth in sales and an ... of 2011 with record second quarter sales, Carrot surpassed its ... company is now well positioned for the third straight year ...
Cached Medicine Technology:Biopharma Leaders Discuss Pharma's Future at Pharmaceutical Strategic Alliances in New York 2Biopharma Leaders Discuss Pharma's Future at Pharmaceutical Strategic Alliances in New York 3Carrot Medical Positioned for Third Straight Year of Triple Digit Growth 2
(Date:8/31/2015)... ... August 31, 2015 , ... Wound Care ... the company’s second Introduction to Hyperbaric Medicine Course. The next UHMS approved 40-hour ... Queen Mary Hotel in Long Beach, CA. The meeting is open for registration ...
(Date:8/31/2015)... NY (PRWEB) , ... August 31, 2015 , ... ... Mesothelioma is a one-day event geared to patients and family members, medical ... by local and regional mesothelioma experts. The conference is a collaborative effort between ...
(Date:8/31/2015)... ... ... Patients who thought about getting a hair transplant but were not sure ... procedure beyond the information found on the Internet can attend the open house event ... be on hand to answer patients hair transplant questions at his next Open ...
(Date:8/31/2015)... Newton, North Carolina (PRWEB) , ... August 31, 2015 , ... ... Abernethy Laurels on Tuesday, September 1. , “Alive Inside” shadows a social ... nonprofit “MUSIC & MEMORY?.” , “It’s a documentary about bringing music to residents in ...
(Date:8/31/2015)... ... August 31, 2015 , ... Garden ... in 2008, the result of a merger of five of the busiest urology ... they could provide more cost-effective and higher quality care than they did individually. ...
Breaking Medicine News(10 mins):Health News:Registration Opens for Wound Care Advantage’s Second UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 2Health News:Registration Opens for Wound Care Advantage’s Second UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 3Health News:Registration Opens for Wound Care Advantage’s Second UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 4Health News:New York Experts on Mesothelioma Come Together at Memorial Sloan Kettering Cancer Center 2Health News:New York Experts on Mesothelioma Come Together at Memorial Sloan Kettering Cancer Center 3Health News:Watch a Live Hair Transplant at Parsa Mohebi Hair Restoration’s Open House 2Health News:Public Invited to Dementia Documentary Screening at North Carolina Retirement Community 2Health News:NJ Top Docs Presents, Garden State Urology! 2
... the most important determinants of an individual,s risk of ... history whether and at what ages close relatives ... for screening examinations such as colonoscopies and mammograms. ... Medical Association a multi-institutional research team reports that ...
... , TUESDAY, July 12 (HealthDay News) -- Among ... patients are more likely than whites to develop the potentially ... pressure ulcers, greatly increase a patient,s cost of care and ... be prevented through proper care, such as helping a patient ...
... rates are higher for men than women in the United ... Biomarkers & Prevention , a journal of the American Association ... investigator in the division of cancer epidemiology and genetics at ... and survival data from the SEER database for 36 cancers ...
... give failing hearts a boost were originally developed as ... as the technology has improved, these ventricular assist devices ... vice-president Dick Cheney, whose implant this month celebrates its ... problems. The power cord that protrudes through the patient,s ...
... The sexually transmitted disease trichomoniasis may be much more common ... are recommending routine screening for sexually active women aged 40 ... prevalent in young people, but our study results clearly show ... even more, older women are infected," said the study,s senior ...
... By Alan Mozes HealthDay Reporter , MONDAY, July ... a perfect time for hitting the beach. But a summer ... much, caution researchers who report that such institutions tend to ... deaths whenever they undergo the massive medical resident turnover that ...
Cached Medicine News:Health News:Changes in family history of cancer can impact screening recommendations 2Health News:Changes in family history of cancer can impact screening recommendations 3Health News:Bed Sores Afflict More Blacks in Nursing Homes Than Whites: Study 2Health News:Cancer mortality rates are higher in men than women 2Health News:Wireless power could cut cord for patients with implanted heart pumps 2Health News:Wireless power could cut cord for patients with implanted heart pumps 3Health News:Older Women at Greater Risk for Common STD, Study Suggests 2Health News:Deaths Up, Care Levels Down at Teaching Hospitals in July 2Health News:Deaths Up, Care Levels Down at Teaching Hospitals in July 3Health News:Deaths Up, Care Levels Down at Teaching Hospitals in July 4
LUMIGAN® is a powerful eye drop medication for lowering IOP. IOP is short for intraocular pressure or eye pressure. LUMIGAN® is the first in a new class of medication....
... New REFRESH LIQUIGEL® Lubricant Eye Drops ... with the convenience of a liquid ... protection. Its extra-strength CMC formula provides ... comfort. And with the PURITE® preservative, ...
Due to its thick formula, REFRESH CELLUVISC Lubricant Eye Drops is ideal for persistent dry eye conditions. REFRESH CELLUVISC provides lasting relief and protection for dry, scratchy eyes....
... solution is an anti-infective prescription ... may instruct you to use ... infection caused by bacteria. Bacterial ... the 2 types of eye ...
Medicine Products: